ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel
K-Number: K213236 · 2022-04-27
Device Summary
Frequently Asked Questions
What is the ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel?
ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel is a medical device that received FDA 510(k) clearance on 2022-04-27. The listed applicant is Genmark Diagnostics, Incorporated. The 510(k) number is K213236.
When did ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel receive FDA 510(k) clearance?
ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel received FDA 510(k) clearance on 2022-04-27, under 510(k) number K213236.
Who is the listed applicant for ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel?
The FDA 510(k) record lists Genmark Diagnostics, Incorporated as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel?
The FDA product code for ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel is PEN.
Other records listing Genmark Diagnostics, Incorporated as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PEN)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.